RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Maia Biotechnology Stock

Maia Biotechnology Net Income 2024

Maia Biotechnology Net Income

-38.66 M USD

Ticker

MAIA

ISIN

US5526411021

In 2024, Maia Biotechnology's profit amounted to -38.66 M USD, a 95.5% increase from the -19.77 M USD profit recorded in the previous year.

The Maia Biotechnology Net Income history

YEARNET INCOME (undefined USD)
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-

Maia Biotechnology Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Maia Biotechnology, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Maia Biotechnology from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Maia Biotechnology’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Maia Biotechnology. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Maia Biotechnology’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Maia Biotechnology’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Maia Biotechnology’s growth potential.

Maia Biotechnology Revenue, EBIT and net profit per share

DateMaia Biotechnology RevenueMaia Biotechnology EBITMaia Biotechnology Net Income
2025e18.05 M undefined-50.87 M undefined-66.58 M undefined
2024e0 undefined-29.43 M undefined-38.66 M undefined
20230 undefined-20.18 M undefined-19.77 M undefined
20220 undefined-16.18 M undefined-16.22 M undefined
20210 undefined-7.79 M undefined-12.5 M undefined
20200 undefined-6.98 M undefined-6.64 M undefined
20190 undefined-6.92 M undefined-6.49 M undefined

Maia Biotechnology stock margins

The Maia Biotechnology margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Maia Biotechnology. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Maia Biotechnology.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Maia Biotechnology's sales revenue. A higher gross margin percentage indicates that the Maia Biotechnology retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Maia Biotechnology's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Maia Biotechnology's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Maia Biotechnology's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Maia Biotechnology. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Maia Biotechnology's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Maia Biotechnology Margin History

Maia Biotechnology Gross marginMaia Biotechnology Profit marginMaia Biotechnology EBIT marginMaia Biotechnology Profit margin
2025e0 %-281.88 %-368.94 %
2024e0 %0 %0 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %

Maia Biotechnology Aktienanalyse

What does Maia Biotechnology do?

Maia Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Maia Biotechnology's Profit Margins

The profit margins of Maia Biotechnology represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Maia Biotechnology's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Maia Biotechnology's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Maia Biotechnology's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Maia Biotechnology’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Maia Biotechnology stock

How much profit has Maia Biotechnology made this year?

Maia Biotechnology has made -38.66 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 95.5% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Maia Biotechnology publish its earnings?

Maia Biotechnology publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Maia Biotechnology?

The profits of Maia Biotechnology are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Maia Biotechnology?

You can learn more about the earnings of Maia Biotechnology by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Maia Biotechnology pay?

Over the past 12 months, Maia Biotechnology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Maia Biotechnology is expected to pay a dividend of 0 USD.

What is the dividend yield of Maia Biotechnology?

The current dividend yield of Maia Biotechnology is .

When does Maia Biotechnology pay dividends?

Maia Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Maia Biotechnology?

Maia Biotechnology paid dividends every year for the past 0 years.

What is the dividend of Maia Biotechnology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Maia Biotechnology located?

Maia Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Maia Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Maia Biotechnology from 11/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/2/2024.

When did Maia Biotechnology pay the last dividend?

The last dividend was paid out on 11/2/2024.

What was the dividend of Maia Biotechnology in the year 2023?

In the year 2023, Maia Biotechnology distributed 0 USD as dividends.

In which currency does Maia Biotechnology pay out the dividend?

The dividends of Maia Biotechnology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Maia Biotechnology

Our stock analysis for Maia Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Maia Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.